{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_7380", "batch_size": 36, "batch_pos": 33, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment uses neutral actions ('secures', 'includes an option').", "method": "llm_batch", "batch_id": "batch_2_19628", "batch_size": 181, "batch_pos": 178, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "Discusses planned action ('secures', 'includes option'), not realised impact.", "method": "llm_batch", "batch_id": "batch_3_21464", "batch_size": 110, "batch_pos": 107, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment contains statements, not a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_20736", "batch_size": 105, "batch_pos": 102, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "The segment provides factual information about deal details without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_15264", "batch_size": 100, "batch_pos": 97, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "Segment contains 'up to 665,000' which is not a minimiser, and lacks scale contrast.", "method": "llm_batch", "batch_id": "batch_6_16588", "batch_size": 38, "batch_pos": 35, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "Segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_17984", "batch_size": 190, "batch_pos": 187, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes 'secures up to 665,000 doses' and 'option for a further 40 million vaccines' (preparedness) without calming language.", "method": "llm_batch", "batch_id": "batch_8_17692", "batch_size": 6, "batch_pos": 3, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
